![Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open- label, phase 3 trial - The Lancet Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open- label, phase 3 trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2094506086/2077189993/gr1.gif)
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open- label, phase 3 trial - The Lancet
![Drug giants threaten NHS with legal action over cheaper drug that could save £84m a year | NHS | The Guardian Drug giants threaten NHS with legal action over cheaper drug that could save £84m a year | NHS | The Guardian](https://i.guim.co.uk/img/media/3d3e9775df68e1820a08c6aff889a11d0224fec4/0_66_3000_1800/master/3000.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctYWdlLTIwMTcucG5n&s=c746753b4b42404a2bea7edbffb28f53)
Drug giants threaten NHS with legal action over cheaper drug that could save £84m a year | NHS | The Guardian
![Genentech: Statements | Genentech Statement on Counterfeit Drug Labeled as Avastin® (Bevacizumab) in the United States Genentech: Statements | Genentech Statement on Counterfeit Drug Labeled as Avastin® (Bevacizumab) in the United States](https://www.gene.com/assets/frontend/img/content/avastin-fake.png)